Sunil G Iyer
Overview
Explore the profile of Sunil G Iyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatt K, Vaynrub A, Cham J, Iyer S, Izar B
Melanoma Res
. 2025 Feb;
PMID: 39903257
While the association between chronic lymphocytic leukemia (CLL) and a higher incidence of melanoma is well documented, the diagnosis of concurrent high-risk chronic myelomonocytic leukemia (CMML) and metastatic melanoma (MM)...
2.
Gui G, Ravindra N, Hegde P, Andrew G, Mukherjee D, Wong Z, et al.
Bone Marrow Transplant
. 2024 Nov;
60(2):154-160.
PMID: 39506075
Measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) in complete remission is an important prognostic marker, but detection methodology requires optimization. Persistence of mutated NPM1 or FLT3-ITD...
3.
Gui G, Ravindra N, Hegde P, Andrew G, Mukherjee D, Wong Z, et al.
Bone Marrow Transplant
. 2024 Oct;
60(2):144-153.
PMID: 39455897
Routine genetic profiling of acute myeloid leukemia (AML) at initial diagnosis has allowed subgroup specific prognostication, drug development, and clinical management strategies. The optimal approach for treatment response assessment for...
4.
Patel A, Yoon J, Johnston H, Davidson M, Shallis R, Chen E, et al.
Blood Adv
. 2024 May;
8(13):3468-3477.
PMID: 38739724
Progression of myeloproliferative neoplasms (MPNs) to accelerated or blast phase is associated with poor survival outcomes. Since 2017 there have been several therapies approved for use in acute myeloid leukemia...
5.
Saul E, Alderuccio J, Reis I, Zhao W, Iyer S, Rodriguez G, et al.
Am J Hematol
. 2022 May;
98(1):148-158.
PMID: 35560252
Comprehensive information on clinical features and long-term outcomes of primary conjunctival extranodal marginal zone lymphoma (PCEMZL) is scarce. We present a large single-institution retrospective study of 72 patients. The median...
6.
Alderuccio J, Saul E, Iyer S, Reis I, Alencar A, Rosenblatt J, et al.
Am J Hematol
. 2021 Mar;
96(6):680-689.
PMID: 33735476
We present long-term combined results of two clinical trials implementing R-MACLO-IVAM induction followed by thalidomide or rituximab maintenance in 44 patients with untreated mantle cell lymphoma (MCL). The first 22...
7.
Benveniste R, Iyer S, Jamshidi A
J Neurosurg Sci
. 2020 Dec;
67(3):324-330.
PMID: 33297611
Background: Delayed subdural fluid collections can occur after Ommaya reservoir placement and can cause neurological symptoms and interfere with treatment. We performed a retrospective chart review to study risk factors...